TY - JOUR
T1 - Measures of growth in children at risk for Huntington disease
AU - Lee, Jessica K.
AU - Mathews, Kathy
AU - Schlaggar, Bradley
AU - Perlmutter, Joel
AU - Paulsen, Jane S.
AU - Epping, Eric
AU - Burmeister, Leon
AU - Nopoulos, Peg
N1 - Funding Information:
Study funding: Supported by 1) a grant from the National Institutes for Neurologic Disorders and Stroke (NINDS) , 5R01NS055903-03 , 2) the CHDI Foundation, 3) a grant from the National Institute of Dental and Craniofacial Research (NIDCR) R01 DE014399-05 , and 4) a grant from the Huntington Disease Society of America, the University of Iowa Huntington Disease Center of Excellence.
PY - 2012/8/14
Y1 - 2012/8/14
N2 - Objective: The effect of mHTT on human development was examined by evaluating measures of growth in children at risk for Huntington disease (HD). Methods: Children at risk for HD with no manifest symptoms (no juvenile HD included) were enrolled and tested for gene expansion for research purposes only. Measurements of growth (height, weight, body mass index [BMI], and head circumference) in children tested as geneexpanded (n = 20, 7-18 years of age, CAG repeats ≥39) were compared to those of a large database of healthy children (n = 152, 7-18 years of age). Results: Gene-expanded children had significantly lower measures of head circumference, weight, and BMI. Head circumference was abnormally low even after correcting for height, suggesting a specific deficit in brain growth, rather than a global growth abnormality. Conclusions: These results indicate that, compared to a control population, children who were estimated to be decades from HD diagnosis have significant differences in growth. Further, they suggest that mHTT may play a role in atypical somatic, and in particular, brain development.
AB - Objective: The effect of mHTT on human development was examined by evaluating measures of growth in children at risk for Huntington disease (HD). Methods: Children at risk for HD with no manifest symptoms (no juvenile HD included) were enrolled and tested for gene expansion for research purposes only. Measurements of growth (height, weight, body mass index [BMI], and head circumference) in children tested as geneexpanded (n = 20, 7-18 years of age, CAG repeats ≥39) were compared to those of a large database of healthy children (n = 152, 7-18 years of age). Results: Gene-expanded children had significantly lower measures of head circumference, weight, and BMI. Head circumference was abnormally low even after correcting for height, suggesting a specific deficit in brain growth, rather than a global growth abnormality. Conclusions: These results indicate that, compared to a control population, children who were estimated to be decades from HD diagnosis have significant differences in growth. Further, they suggest that mHTT may play a role in atypical somatic, and in particular, brain development.
UR - http://www.scopus.com/inward/record.url?scp=84866082207&partnerID=8YFLogxK
U2 - 10.1212/WNL.0b013e3182648b65
DO - 10.1212/WNL.0b013e3182648b65
M3 - Article
C2 - 22815549
AN - SCOPUS:84866082207
SN - 0028-3878
VL - 79
SP - 668
EP - 674
JO - Neurology
JF - Neurology
IS - 7
ER -